UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055866
Receipt number R000063850
Scientific Title A Randomized Controlled Pilot Study of Video Conferencing Versus On-Demand Video in Providing Information on Hereditary Breast and Ovarian Cancer
Date of disclosure of the study information 2024/10/17
Last modified on 2024/10/17 20:40:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Randomized Controlled Pilot Study of Video Conferencing Versus On-Demand Video in Providing Information on Hereditary Breast and Ovarian Cancer

Acronym

A Randomized Controlled Pilot Study of Video Conferencing Versus On-Demand Video in Providing Information on Hereditary Breast and Ovarian Cancer

Scientific Title

A Randomized Controlled Pilot Study of Video Conferencing Versus On-Demand Video in Providing Information on Hereditary Breast and Ovarian Cancer

Scientific Title:Acronym

A Randomized Controlled Pilot Study of Video Conferencing Versus On-Demand Video in Providing Information on Hereditary Breast and Ovarian Cancer

Region

Japan


Condition

Condition

Hereditary Breast and Ovarian Cancer

Classification by specialty

Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

A pilot study to provide information on HBOC via video calls or on-demand video viewing, and to collect data to estimate acceptability and feasibility, as well as eligibility criteria and sample size for subjects in future randomized controlled trials.

Basic objectives2

Others

Basic objectives -Others

Feasibility and acceptance study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Feasibility and Acceptability(Before provision of information, immediately after the provision of information, and one month later)

Key secondary outcomes

Knowledge of BRCA1/2, concerns, satisfaction, problems with intervention, time spent, questions, future plans


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Provide information on HBOC using video calls (Zoom)

Interventions/Control_2

Provide information on HBOC using on-demand videos (Youtube).

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Research subjects must meet the conditions in (1) or (2) and all of the eligibility criteria in (3) and beyond.
(1) Female patients diagnosed with breast cancer before 2020
(2) Female patients with a third-degree relative diagnosed with breast cancer at any time in the past.
(3) Patients aged 18 years or older at the time of obtaining consent
(4) Those who can communicate in Japanese
(5) Those who have a computer, tablet or smartphone and can connect to the internet
(6) Those who have obtained written consent from the person themselves to participate in the research via Google Forms

Key exclusion criteria

The following criteria will be used to exclude participants.
(1) Patients who have received medical treatment for a diagnosis or suspicion of HBOC, or their blood relatives (regardless of the degree of relatedness)
(2) Those who have received information about HBOC from a medical care provider.
(3) Those who are qualified as doctors, nurses, or genetic counselors.

Target sample size

32


Research contact person

Name of lead principal investigator

1st name Yuriko
Middle name
Last name Shibuya

Organization

St. Luke's International University

Division name

Graduate School of Nursing Science Doctoral Course Student

Zip code

104-0044

Address

10-1 Akashi-chou, Chuo-ku, Tokyo, Japan

TEL

03-3543-6391

Email

21dn011@slcn.ac.jp


Public contact

Name of contact person

1st name Yuriko
Middle name
Last name Shibuya

Organization

St. Luke's International University

Division name

Graduate School of Nursing Science Doctoral Course Student

Zip code

1040044

Address

10-1 Akashi-chou, Chuo-ku, Tokyo, Japan

TEL

03-3543-6391

Homepage URL


Email

21dn011@slcn.ac.jp


Sponsor or person

Institute

St. Luke's International University

Institute

Department

Personal name

Yuriko Shibuya


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

St. Luke's International University

Address

10-1 Akashi-chou, Chuo-ku, Tokyo, Japan

Tel

03-3543-6391

Email

21dn011@slcn.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 10 Month 17 Day

Date of IRB


Anticipated trial start date

2024 Year 10 Month 31 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 10 Month 17 Day

Last modified on

2024 Year 10 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063850